Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Antiviral effect of oxetanocin G against guinea pig cytomegalovirus infection in vitro and in vivo.

Yamamoto N, Yamada Y, Daikoku T, Nishiyama Y, Tsutsui Y, Shimada N, Takahashi K.

J Antibiot (Tokyo). 1990 Dec;43(12):1573-8.

2.

Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.

Fong CK, Cohen SD, McCormick S, Hsiung GD.

Antiviral Res. 1987 Jan;7(1):11-23.

PMID:
3026243
3.

Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.

Yang ZH, Lucia HL, Tolman RL, Colonno RJ, Hsiung GD.

Antimicrob Agents Chemother. 1989 Sep;33(9):1563-8.

4.

Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro.

Nishiyama Y, Yamamoto N, Yamada Y, Daikoku T, Ichikawa Y, Takahashi K.

J Antibiot (Tokyo). 1989 Dec;42(12):1854-9.

5.

Combined treatment with 2'-nor-cGMP and ganciclovir against cytomegalovirus infection in a guinea pig model.

Feng JS, Crouch JY, Tolman RL, Lucia HL, Hsiung GD.

Antiviral Res. 1992 Sep;19(3):193-206.

PMID:
1332604
6.
8.

In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.

Duke AE, Smee DF, Chernow M, Boehme R, Matthews TR.

Antiviral Res. 1986 Aug;6(5):299-308.

PMID:
3021055
9.

Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G.

Nishiyama Y, Yamamoto N, Takahash K, Shimada N.

Antimicrob Agents Chemother. 1988 Jul;32(7):1053-6.

10.

Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus.

Kim HT, Kim DK, Kim YW, Kim KH, Sugiyama Y, Kikuchi M.

Antiviral Res. 1995 Nov;28(3):243-51.

PMID:
8629816
11.

Combined antiviral effects of paired nucleosides against guinea pig cytomegalovirus replication in vitro.

Yang ZH, Crouch JY, Feng JS, Chou TC, Hsiung GD.

Antiviral Res. 1990 Oct-Nov;14(4-5):249-65.

PMID:
1965111
13.

Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G.

Daikoku T, Yamamoto N, Saito S, Kitagawa M, Shimada N, Nishiyama Y.

Biochem Biophys Res Commun. 1991 Apr 30;176(2):805-12.

PMID:
1851005
14.

Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine.

Barnard DL, Huffman JH, Sidwell RW, Reist EJ.

Antiviral Res. 1993 Sep;22(1):77-89.

PMID:
8250544
15.

Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.

Koyano S, Suzutani T, Yoshida I, Azuma M.

Antimicrob Agents Chemother. 1996 Apr;40(4):920-3.

16.

Efficacy of S26308 against guinea pig cytomegalovirus infection.

Chen M, Griffith BP, Lucia HL, Hsiung GD.

Antimicrob Agents Chemother. 1988 May;32(5):678-83.

17.

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.

Freitas VR, Smee DF, Chernow M, Boehme R, Matthews TR.

Antimicrob Agents Chemother. 1985 Aug;28(2):240-5.

19.

Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.

Woolf NK, Ochi JW, Silva EJ, Sharp PA, Harris JP, Richman DD.

Antimicrob Agents Chemother. 1988 Jun;32(6):865-72.

20.

In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.

Hostetler KY, Rybak RJ, Beadle JR, Gardner MF, Aldern KA, Wright KN, Kern ER.

Antivir Chem Chemother. 2001 Jan;12(1):61-70.

PMID:
11437323
Items per page

Supplemental Content

Write to the Help Desk